Skip to content
Home/Companies/Biotech/Breye Therapeutics

Breye Therapeutics

Biotech·Denmark·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Breye Therapeutics?

Breye Therapeutics is currently owned by Novo Holdings through Novo Holdings Seed Investments (1999 vintage), since 2022.

Hand-verified · updated 2026-08-18

Novo Holdings
Investor
Novo Holdings
Novo Holdings Seed Investments · 1999 · VC

Key facts

HQDenmark
SectorBiotech
StatusActive

More from Novo Holdings Seed Investments

Other portfolio companies in the same fund.

cAMPfield
Active
BiotechUS· 2026
Coultreon Biopharma
Active
BiotechUS· 2026
QuantumCell
Active
BiotechDenmark· 2025
Booster Therapeutics
Active
BiotechGermany· 2024
Orbis Medicines
Active
BiotechDenmark· 2024
RheumaLogics
Active
BiotechDenmark· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Breye Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Breye Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Breye Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue